Colonoscopy

Jump to

Lupin launches generic drug to treat depression in US

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded and generic formulations, biotechnology products and APIs globally.
Suprep kit approval may add 5% to Lupin‘s EPS: Credit Suisse

Brokerage houses sees record revenue addition and EPS on the back of a â€˜surprising approval‘ by the US FDA. However, it also foresees high competition after the exclusivity period ends.
Lupin gets USFDA nod to market pain relief, colonoscopy drugs

In a BSE filing, Lupin said it has "received final approval for its Oxycodone and Acetaminophen Tablets USP, 2.5 mg/325 mg, 5 mg/325 mg, 7.5 mg/325 mg and 10 mg/325 mg from the United States Food and Drug Administration (FDA) to market a generic version of Vintage Pharmaceuticals LLC's Percocet tablets".

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Colonoscopy

Lupin launches generic drug to treat depression in US

Suprep kit approval may add 5% to Lupin‘s EPS: Credit Suisse

Lupin gets USFDA nod to market pain relief, colonoscopy drugs